Behavioral Incentives to Increase Caregiver Engagement in Juvenile Drug Courts

提高看护者参与青少年毒品法庭的行为激励

• 批准号: 9327060
• 负责人: PHILLIPPE Belton CUNNINGHAM
• 金额: $ 73.55万
• 依托单位: MEDICAL UNIVERSITY OF SOUTH CAROLINA
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-08-05 至 2021-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9327060
• 关键词: Abstinence; Address; Adherence; Adolescent; Adoption; Adult; Behavior; Behavior Therapy; Behavioral; Caregivers; Child; Communities; Crime; Criminal Justice; Development; Drug Courts; Drug usage; Effectiveness; Emotional; Enrollment; Etiology; Family; Family member; Frequencies; Funding; Goals; Health Personnel; Hearing; Incentives; Individual; Institutes; Intervention; Justice; Lead; Literature; Maintenance; Measures; Modality; Modeling; Motivation; Observational Study; Outcome; Parents; Participant; Pharmaceutical Preparations; Pharmacotherapy; Play; Population; Preclinical Drug Evaluation; Prize; Problem behavior; Procedures; Process; Public Health; Randomized; Randomized Clinical Trials; Randomized Controlled Clinical Trials; Recommendation; Reporting; Research Support; Role; Science; Services; Societies; Substance abuse problem; System; Teenagers; Therapeutic; Treatment outcome; Underserved Population; Urine; Youth; adolescent drug abuse; adolescent drug use; adolescent substance abuse; adolescent substance use; base; behavior change; clinical care; contingency management; cost; court; court personnel; criminal offending; design; drug abstinence; effective therapy; evidence base; extrinsic motivation; high risk; improved; indexing; innovation; juvenile delinquent; motivational intervention; parental involvement; primary caregiver; programs; public health relevance; recidivism; reduced substance use; reinforcer; substance abuse treatment; treatment as usual; young adult; Abstinence; Address; Adherence; Adolescent; Adoption; Adult; Behavior; Behavior Therapy; Behavioral; Caregivers; Child; Communities; Crime; Criminal Justice; Development; Drug Courts; Drug usage; Effectiveness; Emotional; Enrollment; Etiology; Family; Family member; Frequencies; Funding; Goals; Health Personnel; Hearing; Incentives; Individual; Institutes; Intervention; Justice; Lead; Literature; Maintenance; Measures; Modality; Modeling; Motivation; Observational Study; Outcome; Parents; Participant; Pharmaceutical Preparations; Pharmacotherapy; Play; Population; Preclinical Drug Evaluation; Prize; Problem behavior; Procedures; Process; Public Health; Randomized; Randomized Clinical Trials; Randomized Controlled Clinical Trials; Recommendation; Reporting; Research Support; Role; Science; Services; Societies; Substance abuse problem; System; Teenagers; Therapeutic; Treatment outcome; Underserved Population; Urine; Youth; adolescent drug abuse; adolescent drug use; adolescent substance abuse; adolescent substance use; base; behavior change; clinical care; contingency management; cost; court; court personnel; criminal offending; design; drug abstinence; effective therapy; evidence base; extrinsic motivation; high risk; improved; indexing; innovation; juvenile delinquent; motivational intervention; parental involvement; primary caregiver; programs; public health relevance; recidivism; reduced substance use; reinforcer; substance abuse treatment; treatment as usual; young adult

 DESCRIPTION (provided by applicant): Juvenile offenders with substance abuse problems represent a large and underserved population that is at high risk for persistent deleterious outcomes and long-term costs for themselves, their families, their communities and society. Moreover, a high percentage of juvenile offenders continue to abuse substances and engage in criminal activity into adulthood. Although one juvenile justice intervention, Juvenile Drug Court (JDC), has emerged as a promising model for reducing the cycle of drug use, crime and delinquency among youth, evidence of its effectiveness is variable. One important factor that may compromise drug court effectiveness is lack of caregiver engagement in JDC processes and concomitant adolescent drug treatment. Incorporating evidence-based incentive programs in JDCs to increase caregiver engagement may improve their effectiveness in reducing youth drug use and criminal re-offending. An extensive body of research supports the critical role that families play in the etiology, maintenance, and treatment of adolescent substance abuse. Although family-based interventions for adolescent substance abuse have been shown to be superior to other treatment modalities, parents must attend treatment and participate in meaningful ways for these superior outcomes to be realized. This R01 Stage II randomized clinical trial will examine the efficacy of a prize-based contingency management (CM) intervention for increasing caregiver engagement (attendance and participation) in JDC and adolescent drug treatment. This caregiver CM intervention (CCM) will be compared with drug court treatment as usual (TAU). One hundred and eighty youth enrolled in JDC will be randomly assigned along with a parent/caregiver to treatment as usual or CCM. Repeated measures analyses will examine the effects of CCM on measures of caregiver engagement in JDC. Analyses will also examine whether improved caregiver engagement contributes to reductions in youth substance use (urine drug screens) and criminal activity. Results from this study are predicted to demonstrate the effectiveness of CCM procedures for increasing caregiver attendance and participation in JDC and adolescent drug treatment above and beyond drug court and usual care. If effective, the CCM approach may ultimately be used to enhance JDC outcomes, thereby reducing substance use and recidivism in juvenile offenders served by this promising juvenile justice intervention. Thus this project has high significance in terms of potential public health impact and reduction in criminal justice system costs. Further, the proposed study is highly innovative because it is among the first to apply CM treatment to JDC, uses an approach designed to be easy to implement within the JDC context, and the first to examine the efficacy of CM for enhancing parental engagement in the JDC process.

 描述（由适用提供）：患有药物滥用问题的少年罪犯代表了一个庞大且服务不足的人群，其持续有害结果和长期成本的高风险是他们自己，他们的家人，社区和社会。此外，很大一部分少年罪犯继续滥用物质，并在成年后从事犯罪活动。尽管一种少年司法干预，即少年毒品法院（JDC），已成为减少青年毒品使用，犯罪和犯罪周期的承诺模型，但其有效性的证据是可变的。可能损害药物法院有效性的一个重要因素是在JDC过程中缺乏照顾者参与和随之而来的青少年药物治疗。在JDC中纳入基于证据的激励计划以增加照顾者的参与度，可以提高其在减少青年吸毒和犯罪再罪方面的有效性。人们对青少年药物滥用的广泛干预措施已被证明优于其他治疗方式，父母必须参加治疗，并以有意义的方式参加这些卓越的结果。这项R01 II期随机临床试验将研究基于奖品的应急管理（CM）干预措施，以增加JDC和青少年药物治疗中的护理人员参与度（出勤和参与）。该护理人员CM干预（CCM）将与往常一样（TAU）进行比较。 JDC招收的一百八十名青年将像往常或CCM一样随机分配给父母/照顾者。重复测量分析将检查CCM对JDC中护理人员参与度的测量的影响。分析还将检查改善的护理人员参与是否有助于减少青少年药物使用（尿液药物筛查）和犯罪活动。预计这项研究的结果将证明CCM程序的有效性增加了护理人员的出勤率，并参与了JDC和青少年药物治疗，超越了药物法院和通常的护理。如果有效，则最终可以使用CCM方法来增强JDC的结果，从而减少这种承诺少年司法干预所服务的少年罪犯的物质使用和累犯。该项目在潜在的公共卫生影响和刑事司法系统成本的降低方面具有很高的意义。此外，拟议的研究具有很高的创新性，因为它是最早将CM治疗方法应用于JDC的方法之一，它使用一种旨在在JDC环境中易于实施的方法，也是第一个研究CM在JDC过程中提高父母参与度的有效性。